Somatic hypermutation signature in B-cell low-grade lymphomas
暂无分享,去创建一个
Nerea Martínez | Mohit Aggarwal | Juan F. García | A. Sánchez-Aguilera | M. Piris | M. Sánchez-Beato | N. Martínez | P. Algara | F. Camacho | R. Villuendas | M. Mollejo | L. Tracey | M. Aggarwal | M. García-Cosío | Antonia Rodríguez | E. Ruíz-Ballesteros | Manuela Mollejo | Miguel A Piris | Margarita Sánchez-Beato | Abel Sánchez-Aguilera | Antonia Rodríguez | Francisca I Camacho | Patrocinio Algara | Juan F García | Lorraine Tracey | Mónica García-Cosio | Raquel Villuendas | Elena Ruiz-Ballesteros | M. García‐Cosío | N. Martínez | Antonia Rodríguez | A. Sánchez-Aguilera | Elena Ruíz-Ballesteros
[1] N A Kolchanov,et al. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. , 1992, Biochimica et biophysica acta.
[2] E. Iannitto,et al. Splenic Marginal Zone Lymphoma , 2021, Hematologic Malignancies.
[3] M. Piris,et al. Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation , 2007, Leukemia.
[4] M. Ghielmini,et al. IgVH mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome , 2005, The Journal of pathology.
[5] S. Cajal,et al. Immunohistochemical analysis of ZAP‐70 expression in B‐cell lymphoid neoplasms , 2005, The Journal of pathology.
[6] E. Campo,et al. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. , 2003, Blood.
[7] E. Campo,et al. Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. , 2005, Blood.
[8] Jaime Prilusky,et al. GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support , 1998, Bioinform..
[9] H. Döhner,et al. High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia , 2004, Leukemia.
[10] A Cumano,et al. Evolutionary and somatic selection of the antibody repertoire in the mouse. , 1987, Science.
[11] Yupo Ma,et al. Immunoglobulin VH somatic hypermutation in mantle cell lymphoma: mutated genotype correlates with better clinical outcome , 2006, Modern Pathology.
[12] D. Lancet,et al. GeneCards: integrating information about genes, proteins and diseases. , 1997, Trends in genetics : TIG.
[13] P. Gearhart,et al. Altered spectra of hypermutation in DNA repair-deficient mice. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[14] Juan F. García,et al. Variability in the Degree of Expression of Phosphorylated IκBα in Chronic Lymphocytic Leukemia Cases With Nodal Involvement , 2004, Clinical Cancer Research.
[15] R. Tsien,et al. Evolution of new nonantibody proteins via iterative somatic hypermutation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[16] Nerea Martínez,et al. The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival. , 2003, Cancer research.
[17] K. Rajewsky,et al. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. , 1993, The EMBO journal.
[18] T. Honjo,et al. Linking class-switch recombination with somatic hypermutation , 2001, Nature Reviews Molecular Cell Biology.
[19] A. Dopazo,et al. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. , 2002, The American journal of pathology.
[20] H. Döhner,et al. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] T. Golub,et al. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. , 2006, Cancer cell.
[22] M. Neuberger,et al. Somatic Hypermutation in the Absence of DNA-Dependent Protein Kinase Catalytic Subunit (DNA-Pkcs) or Recombination-Activating Gene (Rag)1 Activity , 2000, The Journal of experimental medicine.
[23] H. Döhner,et al. Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes. , 2006, Blood.
[24] E. Campo,et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. , 2002, Blood.
[25] J. Benítez,et al. Expression Profiling of T-Cell Lymphomas Differentiates Peripheral and Lymphoblastic Lymphomas and Defines Survival Related Genes , 2004, Clinical Cancer Research.
[26] Nerea Martínez,et al. Expression of the NF‐κB targets BCL2 and BIRC5/Survivin characterizes small B‐cell and aggressive B‐cell lymphomas, respectively , 2005, The Journal of pathology.
[27] A. Dopazo,et al. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. , 2002, The American journal of pathology.
[28] F. Cavalli,et al. Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22‐23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research , 2004, British journal of haematology.
[29] H. Müller-Hermelink,et al. Molecular analysis of human immunoglobulin heavy chain variable genes (IgVH) in normal and malignant B cells. , 1998, The American journal of pathology.
[30] M. Piris,et al. Transcriptional Response of T Cells to IFN-α: Changes Induced in IFN-α-Sensitive and Resistant Cutaneous T Cell Lymphoma , 2004 .
[31] Juan F. García,et al. Variability in the degree of expression of phosphorylated IkappaBalpha in chronic lymphocytic leukemia cases with nodal involvement. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.
[32] César Milstein,et al. The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially , 2001, The EMBO journal.
[33] T J Hamblin,et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.
[34] Adrian Wiestner,et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. , 2003, Blood.
[35] Juan F. García,et al. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. , 2003, Blood.
[36] L. Staudt,et al. Signatures of the immune response. , 2001, Immunity.
[37] L. Pasqualucci,et al. Expression of the AID protein in normal and neoplastic B cells. , 2004, Blood.